A remarkable feature of granulopoiesis is the regulated production and release of neutrophils (PMN) to maintain homeostatic levels in the circulation. The granulocyte colony-stimulating factor receptor (G-CSFR) plays a critical role in this process as the major regulator of myeloid cell proliferation and differentiation and as a modulator of PMN and stem cell mobilization. Deregulation in G-CSFR expression and signaling is linked to neutrophil deficiencies and human leukemias. Despite the critical role that the G-CSFR plays in regulating granulopoiesis and the current widespread clinical use of G-CSF for prevention and/or treatment of neutropenia and for stem cell mobilization, the molecular mechanisms that downregulate G-CSFR expression and signaling to prevent uncontrolled myeloid cell expansion remain unknown. The overall goal of this proposal is to determine the role of ubiquitination in inactivation of the granulocyte colony-stimulating factor receptor (G-CSFR). We hypothesize that ubiquitin-modification of the G-CSFR regulates its expression at the cell surface and its intracellular fate and signaling potency and that defects in G-CSFR ubiquitination contribute to human disease. We will test our hypothesis in the studies proposed in this application using ultrastructural analyses as well as molecular, biochemical, and functional approaches to analyze the dynamics of G-CSFR ubiquitination on receptor trafficking and signaling. We will also investigate whether forced ubiquitination of internalization-incompetent mutant G-CSFR forms from patients with acute myelogenous leukemia (AML) corrects aberrant receptor surface expression and trafficking to reverse the hyperproliferative phenotype. Retroviral transduction of G-CSFR variants into primary cells from G-CSFR null (-/-) mice will allow us to confirm results obtained in cell lines and establish their physiological relevance. Determination of the functional consequences of G-CSFR ubiquitination will provide new insights into the fundamental mechanisms of G-CSFR desensitization which may have therapeutic application for modulation of granulopoiesis and progenitor cell mobilization.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DK068639-02
Application #
7140531
Study Section
Hematopoiesis Study Section (HP)
Program Officer
Wright, Daniel G
Project Start
2005-09-20
Project End
2009-08-31
Budget Start
2006-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2006
Total Cost
$182,483
Indirect Cost
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Kindwall-Keller, Tamila L; Druhan, Lawrence J; Ai, Jing et al. (2008) Role of the proteasome in modulating native G-CSFR expression. Cytokine 43:114-23
Hunter, Melissa G; McLemore, Morgan; Link, Daniel C et al. (2008) Divergent pathways in COS-7 cells mediate defective internalization and intracellular routing of truncated G-CSFR forms in SCN/AML. PLoS One 3:e2452
Ai, Jing; Druhan, Lawrence J; Loveland, Megan J et al. (2008) G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation. PLoS One 3:e3422
Ai, Jing; Druhan, Lawrence J; Hunter, Melissa G et al. (2008) LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation. J Leukoc Biol 83:1277-85